MTD: Catheter, Intracardiac Mapping, High-Density Array
What it covers
An electrode recording catheter or an electrode recording probe is a device used to detect an intracardiac electrocardiogram, or to detect cardiac output or left-to-right heart shunts. The device may be unipolar or multipolar for electrocardiogram detection, or may be a platinum-tipped catheter which senses the presence of a special indicator for cardiac output or left-to-right heart shunt determinations.
The identification in 21 CFR 870.1220, electrode recording catheter or electrode recording probe. FDA gives MTD no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261012 | OptiMap Catheter - 60mm (OPTI-CATH2-60) | Cortex, Inc. | Apr 23, 2026 | Special |
| K253205 | OptiMap Catheter - 50mm (OPTI-CATH2-50) | Cortex, Inc. | Mar 13, 2026 | Traditional |
| K233433 | Sphere-9Dx Diagnostic Catheter (AFR-00009) | Medtronic | Aug 7, 2024 | Traditional |
| K241372 | Advisor HD Grid X Mapping Catheter, Sensor Enabled | ABBOTT MEDICAL | Jul 9, 2024 | Special |
| K231312 | PENTARAY® NAV ECO High Density Mapping Catheter, DECANAV® Mapping Catheter, Webster® CS Catheter with Auto ID, Webster® CS Catheter with EZ Steer Technology, Webster® CS Catheter with EZ Steer Technology with Auto ID | Biosense Webster, Inc. | Jul 10, 2023 | Special |
| K223666 | Ablacath Mapping Catheter | Ablacon, Inc. | Mar 17, 2023 | Traditional |
| K230253 | OPTRELL Mapping Catheter with TRUEref Technology | Biosense Webster, Inc. | Mar 2, 2023 | Special |
| K210766 | AcQMap 3D Imaging and Mapping Catheter, Model 900009 | Acutus Medical, Inc. | Jun 21, 2022 | Traditional |
| K211438 | OPTRELL Mapping Catheter with TRUEref Technology | Biosense Webster, Inc. | Mar 18, 2022 | Traditional |
| K201806 | Reprocessed PentaRay Nav eco High-Density Mapping Catheter | Sterilmed Inc. (Johnson and Johnson) | Jun 23, 2021 | Traditional |
Clearances by year
24 MTD 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 98 |
| 2024 | 2 | 178 |
| 2023 | 3 | 66 |
| 2022 | 2 | 388 |
| 2021 | 1 | 357 |
| 2020 | 4 | 169 |
| 2018 | 1 | 258 |
| 2017 | 2 | 135 |
| 2016 | 1 | 164 |
| 2014 | 2 | 34 |
| 2013 | 2 | 151 |
| 2012 | 2 | 66 |
Who submits
13 applicants cleared a MTD device since 2011. 100% of the clearances went to applicants in United States. By type: Traditional 71% and Special 29%.
| Applicant | Clearances since 2011 |
|---|---|
| Biosense Webster, Inc. | 7 |
| Acutus Medical, Inc. | 3 |
| Abbott Electrophysiology | 2 |
| Cortex, Inc. | 2 |
| Topera, Inc. | 2 |
| ABBOTT MEDICAL | 1 |
| Ablacon, Inc. | 1 |
| Boston Scientific Corporation | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.1220.
Standards
21 CFR 870.1220 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MTD clearances declared.
Ask about MTD
Questions about MTD
What is FDA product code MTD?
Product code MTD, “Catheter, Intracardiac Mapping, High-Density Array” in FDA's classification database, is a Class II device type under 21 CFR 870.1220 (electrode recording catheter or electrode recording probe), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 34 clearances under MTD, 24 of them since 2011.
How many 510(k) clearances are there under MTD?
FDA’s 510(k) database listed 34 clearances under MTD as of Oct 29, 2026, 24 of them decided since 2011; the most recent decision was Apr 23, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a MTD 510(k)?
For the 2 MTD clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 98 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most MTD clearances?
Since 2011: Biosense Webster, Inc. (7), Acutus Medical, Inc. (3), Abbott Electrophysiology (2), Cortex, Inc. (2) and Topera, Inc. (2). 13 applicants have cleared a MTD device in that time.